Titan Medical Inc.
TMDIF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $18 | $0 | $20 | $21 |
| % Growth | – | -100% | -5.4% | – |
| Cost of Goods Sold | $0 | $1 | $0 | $0 |
| Gross Profit | $18 | -$1 | $20 | $21 |
| % Margin | 98.9% | – | 100% | 100% |
| R&D Expenses | $0 | $31 | $38 | $8 |
| G&A Expenses | $8 | $12 | $13 | $8 |
| SG&A Expenses | $8 | $11 | $12 | $8 |
| Sales & Mktg Exp. | -$0 | -$1 | -$0 | $0 |
| Other Operating Expenses | -$1 | $0 | $1 | $0 |
| Operating Expenses | $7 | $42 | $50 | $16 |
| Operating Income | $10 | -$43 | -$31 | $4 |
| % Margin | 57.4% | – | -154.2% | 21% |
| Other Income/Exp. Net | $2 | $2 | $16 | -$30 |
| Pre-Tax Income | $7 | -$41 | -$15 | -$25 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | $7 | -$41 | -$15 | -$25 |
| % Margin | 38.7% | – | -73.9% | -120.9% |
| EPS | 0.061 | -0.37 | -0.14 | -0.38 |
| % Growth | 116.4% | -164.3% | 63.2% | – |
| EPS Diluted | 0.061 | -0.37 | -0.14 | -0.38 |
| Weighted Avg Shares Out | 117 | 112 | 108 | 67 |
| Weighted Avg Shares Out Dil | 117 | 112 | 108 | 67 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $0 | $1 | $1 | $0 |
| EBITDA | $8 | -$40 | -$14 | -$23 |
| % Margin | 41.9% | – | -69.6% | -108.5% |